New eye drops show promise for fast dry eye relief

NCT ID NCT06309953

Completed Symptom relief Sponsor: Bausch & Lomb Incorporated Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested Miebo eye drops in 99 adults with dry eye disease. Participants used one drop in each eye four times daily for 14 days. The main goal was to see how much dry eye symptoms improved after one week, measured on a 0-to-100 scale. The study is complete, but results are not yet published.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Miebo (perfluorohexyloctane ophthalmic solution)
What this could lead to: If successful, this could confirm that Miebo quickly relieves dry eye symptoms within a week, offering a new option for people with dry eye disease.
What could go wrong: This is a small, completed Phase 4 trial with no control group, so results may not prove effectiveness compared to placebo or other treatments. Individual results may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY EYE

Contacts and locations

Locations

Site 201

Brecksville, Ohio, 44141, United States
Site 202

Kansas City, Missouri, 64154, United States
Site 203

Pittsburg, Kansas, 66762, United States
Site 204

Stillwater, Minnesota, 55082, United States
Site 205

Petaluma, California, 94954, United States
Site 206

Westlake, Ohio, 44145, United States
Site 207

Birmingham, Alabama, 35233, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.